Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Former Pharmaceutical Executive Sentenced in Drug Counterfeiting Case

By Pharmaceutical Processing | November 22, 2004

WASHINGTON, DC (November 22, 2004) – The former president and chief executive officer of NuCare Pharmaceuticals, Inc. was sentenced to 21 months in federal prison, followed by 3 years of supervised probation, for two counts of mail fraud for his role in a kickback scheme involving counterfeit and diverted prescription drugs, the Food & Drug Administration (FDA) said.

District Court Judge Howard F. Sachs also ordered Christopher Wayne Lamoreaux, 38, of Anaheim, CA to pay $115,278.54 in restitution to NuCare, the firm that he defrauded. Lamoreaux was convicted of the charges in July.

Todd P. Graves, United States Attorney for the Western District of Missouri, successfully prosecuted Lamoreaux following an investigation conducted by the FDA’s Office of Criminal Investigation.

Lamoreaux defrauded his employer by accepting secret kickbacks for negotiating a contract for the company to purchase counterfeit and diverted prescription drugs from a Missouri pharmaceutical firm, and repack these drugs for further sale.

“The FDA’s Office of Criminal Investigation and U.S. Attorney’s office are to be commended for their work in exposing and pursuing those who deal in drug counterfeiting,” said Dr. Lester M. Crawford, acting FDA commissioner. “Those who attempt to peddle counterfeit drugs endanger lives and the integrity of our country’s drug supply. This sentence sends the appropriate message to those who would consider such a dangerous and illegal activity.”

NuCare, a licensed re-packager of prescription drugs, also supplies drugs to urgent care facilities, indigent patient clinics, and occupational health clinics.

In late 2002, Lamoreaux negotiated a contract with Albers Medical, Inc., on behalf of NuCare. Under the agreement, Graves said, NuCare purchased Lipitor and Bextra on consignment from Albers, repackaged the drugs at its facility, and then shipped the repacked drugs to Med-Pro, another repackaging company located in Lexington, NE.

NuCare paid Lamoreaux a commission of $1,692 for bringing in the business from Albers, unaware that Lamoreaux had received the more than $115,000 in kickbacks from Albers and others involved in the transactions. On March 11, 2003, Lamoreauxabruptly resigned from NuCare. Shortly thereafter, the company learned of the fraud scheme from FDA investigators.

The drugs NuCare repackaged were ultimately distributed by Albers throughout the United States. Much of the Lipitor involved in the repackaging was later determined by the FDA to be counterfeit.

Related Articles Read More >

This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
PHARMAP 2025: Pharma leaders converge in Berlin for fifth anniversary summit
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE